Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis

Circulation: Cardiovascular Interventions

Volumn 9, Issue 4, 2016, Pages

  Pleva, Leos ^a   Kukla, Pavel ^a   Kusnierova, Pavlina ^b   Zapletalova, Jana ^c   Hlinomaz, Ota ^d  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

coronary restenosis; diabetes mellitus; drug eluting stents; paclitaxel; stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; EVEROLIMUS; PACLITAXEL;

ADULT; ANTICOAGULANT THERAPY; ARTERY DIAMETER; ARTICLE; BALLOON CATHETER; BARE METAL STENT; DIABETES MELLITUS; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; GUIDING CATHETER; HEART DISEASE; HUMAN; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PACLITAXEL ELUTING BALLOON CATHETER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; X RAY SYSTEM; ADVERSE EFFECTS; AGED; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CZECH REPUBLIC; DEVICES; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; KAPLAN MEIER METHOD; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDY; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE;

AGED; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CZECH REPUBLIC; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; EVEROLIMUS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84964504898     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.003316     Document Type: Article

References (31)

1. Kim MS, Dean LS, In-stent restenosis. Cardiovasc Ther 2011 29 190 198. doi: 10.1111/j.1755-5922.2010.00155.x.
2. Alfonso F, Byrne RA, Rivero F, Kastrati A, Current treatment of in-stent restenosis. J Am Coll Cardiol 2014 63 2659 2673. doi: 10.1016/j.jacc.2014.02.545
3. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, Kuntz RE, Fitzgerald PJ, Wang H, Caramanica E, Cohen SA, SISR Investigators Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006 295 1264 1273. doi: 10.1001/jama.295.11.1264
4. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME, TAXUS V ISR Investigators Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006 295 1253 1263. doi: 10.1001/jama.295.11.1253
5. Belkacemi A, Agostoni P, Voskuil M, Doevendans P, Stella P. Drug-eluting balloons in coronary artery disease-current and future perspectives. Interv Cardiol 2011;6:157-160
6. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U, Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006 355 2113 2124. doi: 10.1056/NEJMoa061254
7. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B, Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009 119 2986 2994. doi: 10.1161/CIRCULATIONAHA.108.839282
8. Alfonso F, Fernandez C, Second-generation drug-eluting stents. Moving the field forward. J Am Coll Cardiol 2011 58 26 29. doi: 10.1016/j.jacc.2011.03.013
9. Tsuchida K, Piek JJ, Neumann FJ, Van Der Giessen WJ, Wiemer M, Zeiher AM, Grube E, Haase J, Thuesen L, Hamm CW, Veldhof S, Dorange C, Serruys PW, One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial). EuroIntervention 2005 1 266 272
10. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrié D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J, A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention 2006 2 286 294
11. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ, SPIRIT III Investigators Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 2008 299 1903 1913. doi: 10.1001/jama.299.16.1903
12. Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW, Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol 2008 51 23 32. doi: 10.1016/j.jacc.2007.07.084
13. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction; ESC Committee for Practice Guidelines (CPG) Third universal definition of myocardial infarction. Eur Heart J 2012 33 2551 2567. doi: 10.1093/eurheartj/ehs184
14. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007 115 2344 2351. doi: 10.1161/CIRCULATIONAHA.106.685313
15. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB 3rd, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL Jr, Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988 78 486 502
16. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB, Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999 100 1872 1878
17. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A, ISAR-DESIRE Study Investigators Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005 293 165 171. doi: 10.1001/jama.293.2.165
18. Alfonso F, Pérez-Vizcayno MJ, Hernandez R, Bethencourt A, Martí V, López-Mínguez JR, Angel J, Mantilla R, Morís C, Cequier A, Sabaté M, Escaned J, Moreno R, Bañuelos C, Suárez A, Macaya C, RIBS-II Investigators A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006 47 2152 2160. doi: 10.1016/j.jacc.2005.10.078
19. Sun Y, Li L, Su Q, Lu Y, Comparative efficacy and safety of drug-eluting stent and conventional therapies in coronary heart disease patients with in-stent restenosis: a meta-Analysis. Cell Biochem Biophys 2014 68 211 229. doi: 10.1007/s12013-013-9692-7
20. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Böhm M, Speck U, Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008 97 773 781. doi: 10.1007/s00392-008-0682-5
21. Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, Hayashi Y, Shiode N, Saito S, Ikari Y, Kimura T, Hosokawa J, Nakamura M, Kotani J, Kozuma K, Mitsudo K, A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J 2013 166 527 533. doi: 10.1016/j.ahj.2013.07.002
22. Indermuehle A, Bahl R, Lansky AJ, Froehlich GM, Knapp G, Timmis A, Meier P, Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-Analysis of randomised controlled trials. Heart 2013 99 327 333. doi: 10.1136/heartjnl-2012-302945
23. Gao S, Shen J, Mukku VK, Wang MJ, Akhtar M, Liu W, Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials [published online ahead of print October 18, 2015]. Angiology. doi: 10.1177/0003319715611826
24. Lee MS, Yang T, Mahmud E, Park KW, Kim HS, Kim MH, Dangas G, Hermiller J, Krucoff M, Rutledge D, Clinical outcomes in the percutaneous coronary intervention of in-stent restenosis with everolimus-eluting stents. J Invasive Cardiol 2014 26 420 426
25. Almalla M, Schröder JW, Pross V, Stegemann E, Marx N, Hoffmann R, Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis. Am J Cardiol 2011 108 518 522. doi: 10.1016/j.amjcard.2011.03.080
26. Markovic S, Paliskyte R, Rottbauer W, Wöhrle J, Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses. Cardiovasc Revasc Med 2012 13 307 310. doi: 10.1016/j.carrev.2012.09.003
27. Alfonso F, Pérez-Vizcayno MJ, Cárdenas A, del B, lanco BG, Seidelberger B, Ińiguez A, Gómez-Recio M, Masotti M, Velázquez MT, Sanchís J, García-Touchard A, Zueco J, Bethencourt A, Melgares R, Cequier A, Dominguez A, Mainar V, López-Mínguez JR, Moreu J, Martí V, Moreno R, Jiménez-Quevedo P, Gonzalo N, Fernández C, Macaya C, A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis. JACC 2014 63 1378 1386
28. Lee JM, Park J, Kang J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Kim HS, Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-Analysis of 11 randomized, controlled trials. JACC Cardiovasc Interv 2015 8 382 394. doi: 10.1016/j.jcin.2014.09.023
29. Mamuti W, Ablimit A, Kelimu W, Rao F, Jiamali A, Zhang W, Pei X, Zhang F, Comparison of drug-eluting balloon versus drug-eluting stent in patients with in-stent restenosis: insight from randomized controlled trials. Int J Cardiol 2015 179 424 429. doi: 10.1016/j.ijcard.2014.11.114
30. Goel SS, Gajulapalli RD, Athappan G, Philip F, Gupta S, Tuzcu EM, Ellis SG, Mishkel G, Samir R., Kapadia SR, Management of drug eluting stent in-stent restenosis: a systematic review and meta-Analysis [published online ahead of print November 28, 2015]. Catheter Cardiovasc Interv. doi: 10.1002/ccd.26151
31. Kasaoka S, Tobis JM, Akiyama T, Reimers B, Di Mario C, Wong ND, Colombo A, Angiographic and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998 32 1630 1635